Growth Metrics

Medicale (MCLE) Equity Average (2021 - 2025)

Medicale (MCLE) has disclosed Equity Average for 5 consecutive years, with -$126652.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Equity Average fell 64.87% year-over-year to -$126652.0, compared with a TTM value of -$126652.0 through Jun 2025, down 64.87%, and an annual FY2024 reading of -$69826.5, down 46.24% over the prior year.
  • Equity Average was -$126652.0 for Q2 2025 at Medicale, down from -$119750.5 in the prior quarter.
  • Across five years, Equity Average topped out at $1650.0 in Q2 2021 and bottomed at -$126652.0 in Q2 2025.
  • Average Equity Average over 5 years is -$48959.2, with a median of -$35329.8 recorded in 2022.
  • The sharpest move saw Equity Average crashed 2345.64% in 2022, then surged 50.94% in 2023.
  • Year by year, Equity Average stood at -$17703.0 in 2021, then tumbled by 88.15% to -$33307.5 in 2022, then plummeted by 51.24% to -$50373.5 in 2023, then crashed by 112.96% to -$107273.0 in 2024, then fell by 18.07% to -$126652.0 in 2025.
  • Business Quant data shows Equity Average for MCLE at -$126652.0 in Q2 2025, -$119750.5 in Q1 2025, and -$107273.0 in Q4 2024.